Dr. Morano discusses the initial work-up and evaluation of the HIV positive patient. The first of two parts.
Archives
Bartonellosis
Dr Antoneh Addisu describes the history and taxonomy of Bartonella species, including basic microbiology of this important organism. He differentiates between the major syndromes caused by Bartonella organisms and associates them with specific species. Diagnostic considerations are also discussed. A more obscure manifestation of Bartonella infection is culture negative endocarditis, which is also reviewed. Lastly, the speaker discusses therapy for Bartonella infections.
STD Update for 2017 (Florida)
Dr. Maria L Alcaide, Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine, presents an update on sexually transmitted diseases with a emphasis on the state of Florida. She focuses on recent epidemiology, specific syndromes including syphilis, urethritis and the genital ulcer diseases, as well as HIV-STD interactions.
Invasive Fungal Infections
Flu Update 2016-7
Antibiotic Stewardship in Oncologic Care
Dr. Baluch covers the necessary steps to establish and conduct a successful antibiotic stewardship program in an oncology hospital. She covers population specific factors in the immunocompromised population, laboratory diagnostic resources, core elements, recruiting necessary personnel for the ASP team, and how to be compliant with accreditation standards.
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Nocardiosis
Non-Tuberculous Mycobacteria Update
Mycology Papers Update for 2016
Dr. Wonhee So, ID clinical Pharmacist at Moffitt Cancer Center and Research Institute, presents several important recent papers in the field of fungal infection diagnosis and management, and offers clinical commentary on their significance to the practice of infectious diseases in the immunocompromised patient. Dr. So covers such topics as the use of dexamethasone in the treatment of cryptococcal meningitis, the radiologic diagnosis of lung mould infections in AML, the use of Isuvaconazole in Mucor infections, and the use of combination anti fungal therapy.